Global Clinical Trial Disclosure: What Noncompliance Penalties Are in Place, & How They Are Enforced
White paper
Regulatory & Compliance
In the wake of the coronavirus pandemic, pressure has come from regulatory agencies, the public, patients, advocates, pharmaceutical industry watchdogs, and investors for increased clinical transparency. This white paper takes a look at a broad spectrum of global disclosure regulations, whether penalties exist for noncompliance and, if so, whether they are being enforced.
Failure to register and fully report clinical trials harms patients, wastes taxpayers’ money, and slows down the development of new treatments, vaccines and cures.
TrialScope Disclose
Manage the complexity of clinical trial disclosure and the risk of non-compliance by automating data entry and reporting to registries
TrialScope Intelligence
A centralized, interactive repository of the critical regulatory knowledge needed for global clinical trial disclosure compliance
Trial Summaries
This user-friendly portal aggregates clinical trial results summaries across sponsors
